4//SEC Filing
Xie Jian 4
Accession 0001193125-25-304294
CIK 0001674930other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 9:14 PM ET
Size
6.4 KB
Accession
0001193125-25-304294
Insider Transaction Report
Form 4
Xie Jian
President and COO
Transactions
- Sale
Common Stock
2025-11-28$29.57/sh−1,198$35,424→ 337,889 total
Holdings
- 220,816(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.
- [F2]The shares were sold in multiple transactions at prices ranging from $29.45 to $29.67, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001819718
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 9:14 PM ET
- Size
- 6.4 KB